Join
Live feed
·
PRReleasevia Quantisnow
Intercept Pharmaceuticals Inc. logo

Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBC

ByQuantisnow·Wall Street's wire, on your screen.
ICPT· Intercept Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ICPT (Intercept Pharmaceuticals Inc.) and more on Quantisnow.